Increased serum resistin concentration in patients with chronic pancreatitis: Possible cause of pancreatic fibrosis

Journal of Clinical Gastroenterology

Volumn 43, Issue 1, 2009, Pages 63-68

  Adrych, Krystian ^a   Smoczynski, Marian ^a   Sledzinski, Tomasz ^a   Dettlaff Pokora, Agnieszka ^a   Goyke, Elzbieta ^a   Swierczynski, Julian ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adiponectin; BMI; Chronic pancreatitis; Leptin; Resistin

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN; RESISTIN;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

ADIPONECTIN; ADULT; AGED; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROSIS; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; PANCREATITIS, CHRONIC; RADIOIMMUNOASSAY; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67651174429     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31815cda0a     Document Type: Article

References (41)

1. Ammann RW. A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis. Pancreas. 1997;3:215-221.
2. Forsmark CE. Chronic pancreatitis. In: Feldman M, Friedman FS, Sleisenger MH, eds. Gastrointestinal and Liver Disease. Philadelphia London-New York, St Louis, Sydney, Toronto: WB Saunders Company; 2002:943-969.
3. Sarles H. Definitions and classifications of pancreatitis. Pancreas. 1991;4:470-474.
4. Hackert T, Hartwig W, Friess H, et al. Acute retinopathy following pancreatic head resection for chronic pancreatitis: a rare, severe complication. JOP. 2005;5:460-463. (Pubitemid 41574043)
5. DiMagno MJ, DiMagno EP. Chronic pancreatitis. Curr Opin Gastroenterol. 2005;5:544-554.
6. Stevens T, Conwell DL, Zuccaro G. Pathogenesis of chronic pancreatitis: an evidence-based review of past theories and recent developments. Am J Gastroenterol. 2004;11:2256-2270. (Pubitemid 39524718)
7. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;3: 347-355. (Pubitemid 40277057)
8. Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem. 2007;10:1095-1100. (Pubitemid 46672628)
9. Adrych K, Smoczynski M, Goyke E, et al. Decreased serum leptin concentration in patients with chronic pancreatitis. Pancreas. 2007;4:417-422. (Pubitemid 46725782)
10. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002;1:18-23.
11. Kim KH, Lee K, Moon YS, et al. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001;14:11252-11256. (Pubitemid 38089312)
12. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med. 2004;4:439-447.
13. Yura S, Sagawa N, Itoh H, et al. Resistin is expressed in the human placenta. J Clin Endocrinol Metab. 2003;3:1394-1397.
14. Minn AH, Patterson NB, Pack S, et al. Resistin is expressed in pancreatic islets. Biochem Biophys Res Commun. 2003;2: 641-645.
15. Anderson PD, Mehta NN, Wolfe ML, et al. Innate Immunity Modulates Adipokines in Humans. J Clin Endocrinol Metab. 2007;92:2272-2279.
16. McTernan PG, Kusminski CM, Kumar S. Resistin. Curr Opin Lipidol. 2006;2:170-175.
17. Pang SS, Le YY. Role of resistin in inflammation and inflammation- related diseases. Cell Mol Immunol. 2006;1:29-34.
18. Kaser S, Kaser A, Sandhofer A, et al. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003;2:286-290. (Pubitemid 37025889)
19. Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;9:5789-5795. (Pubitemid 40593223)
20. Silswal N, Singh AK, Aruna B, et al. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005;4:1092-1101. (Pubitemid 41074686)
21. Verma S, Li SH, Wang CH, et al. Resistin promotes endothelial cell activation: further evidence of adipokineendothelial interaction. Circulation. 2003;6:736-740. (Pubitemid 36999260)
22. Schaffler A, Buchler C, Muller-Ladner U, et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res. 2004;10: 702-707. (Pubitemid 39486971)
23. Pagano C, Soardo G, Pilon C, et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab. 2006;3:1081-1086. (Pubitemid 43357784)
24. Karmiris K, Koutroubakis IE, Xidakis C, et al. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis. 2006;2:100-105.
25. Schaffler A, Landfried K, Volk M, et al. Potential of adipocytokines in predicting peripancreatic necrosis and severity in acute pancreatitis: pilot study. J Gastroenterol Hepatol. 2007;3:326-334. (Pubitemid 46238760)
26. Homma T. Criteria for pancreatic disease diagnosis in Japan: diagnostic criteria for chronic pancreatitis. Pancreas. 1998;3: 250-254. (Pubitemid 28158025)
27. Sarner M, Cotton PB. Classification of pancreatitis. Gut. 1984;7: 756-759.
28. Szuster-Ciesielska A, Daniluk J, Kandefer-Zerszen M. Serum levels of cytokines in alcoholic liver cirrhosis and pancreatitis. Arch Immunol Ther Exp (Warsz). 2000;4:301-307.
29. Azuma K, Katsukawa F, Oguchi S, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res. 2003;8:997-1001. (Pubitemid 41137512)
30. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab. 2003;11:5452-5455. (Pubitemid 37452753)
31. Fujinami A, Obayashi H, Ohta K, et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta. 2004;1-2:57-63. (Pubitemid 37542458)
32. Vozarova de Court B, Degawa-Yamauchi M, Considine RV, et al. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes. 2004;5:1279-1284. (Pubitemid 38569014)
33. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulinresistant, and diabetic subjects. J Clin Endocrinol Metab. 2003;10: 4848-4856. (Pubitemid 37357535)
34. Takeishi Y, Niizeki T, Arimoto T, et al. Serum resistin is associated with high risk in patients with congestive heart failure-a novel link between metabolic signals and heart failure. Circ J. 2007;4:460-464. (Pubitemid 46513449)
35. Silha JV, Krsek M, Skrha JV, et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003;4:331-335. (Pubitemid 37304704)
36. Zhang JL, Qin YW, Zheng X, et al. Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet Med. 2003;10:828-831. (Pubitemid 41701504)
37. Panidis D, Koliakos G, Kourtis A, et al. Serum resistin levels in women with polycystic ovary syndrome. Fertil Steril. 2004;2: 361-366. (Pubitemid 38223917)
38. Xie MJ, Motoo Y, Su SB, et al. Expression of tumor necrosis factor-alpha, interleukin-6, and interferon-gamma in spontaneous chronic pancreatitis in the WBN/Kob rat. Pancreas. 2001;4:400-408. (Pubitemid 32402091)
39. Mews P, Phillips P, Fahmy R, et al. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut. 2002;4:535-541. (Pubitemid 34638875)
40. Saxena NK, Titus MA, Ding X, et al. Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J. 2004;13: 1612-1614. (Pubitemid 39561650)
41. Cho YM, Youn BS, Chung SS, et al. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia. 2004;3:559-565.